• Advanced TB Diagnostic Research  (2012/1/23)
    Advanced TB Diagnostic Research Maximum of 40 participants. Only participants with prior TB diagnostic research experience or advanced training will be eligible. Participants from African institutions and those from TB-NEAT project sites will get preference. View more
  • ADVANCED TB Diagnostic Research  (2012/1/23)
    ADVANCED TB Diagnostic Research This advanced course will cover the principles behind diagnostic research, diagnostic study designs, sources of bias, and value chain for TB diagnostics development. Also, critical appraisal of diagnostic studies, and conventional and advanced methods for systematic reviews (meta-analyses) of diagnostic tests will be presented, along with the GRADE approach to diagnostic policies. More recently, there is growing appreciation that “test accuracy research” focused on sensitivity and specificity is not necessarily the same as “diagnostic research.” View more
  • Frequently ask question What is “totally drug resistant “tuberculosis (TDR-TB) by WHO  (2012/1/17)
    Frequently ask question What is “totally drug resistant “tuberculosis (TDR-TB)  by  WHO In 2006, the first reports of extensively drug-resistant tuberculosis (XDR-TB), an even more severe form of drug resistant TB than multidrug-resistant TB (MDR-TB), began to appear. [1,2] MDR-TB is defined as resistance to isoniazid and rifampicin, with or without resistance to other first-line drugs (FLD). XDR-TB is defined as resistance to at least isoniazid and rifampicin, and to any fluoroquinolone, and to any of the three second-line injectables (amikacin, capreomycin, and kanamycin). Within a year of the first reports of XDR-TB, isolated cases were reported in Europe that had resistance to all first-line anti-TB drugs (FLD) and second-line anti-TB drugs (SLD) that were tested.[3,4,5] In 2009, a cohort of 15 patients in Iran was reported which were resistant to all anti-TB drugs tested.[6] View more
  • Iranian Stop TB Committee  (2012/1/17)
    Iranian Stop TB Committee Iranian Charity Foundation for Tuberculosis and Lung Disease (ICFTLD) with the collaboration of Iranian Ministry of Health decided to establish “Iranian Stop TB Committee” in 2004 to identify the obstacles of NTP and help achieve the National TB Control Programme targets.n We are working as a facilitator toward our vision (reaching a case detection of 70% and cure rate of 85%). View more
  • India Reports Completely Drug-Resistant TB: By Maryn McKenna  (2012/1/17)
    India Reports Completely Drug-Resistant TB:  By Maryn McKenna Maryn McKenna is stating “ TB is already one of the world’s worst killers, up there with malaria and HIV/AIDS, accounting for 9.4 million cases and 1.7 million deaths in 2009, according to the WHO. At the best of times, TB treatment is difficult, requiring at least 6 months of pill combinations that have unpleasant side effects and must be taken long after the patient begins to feel well. View more
  • The High Risk of TB Infection Among Nursing Students in South India  (2011/10/31)
    The High Risk of TB Infection  Among Nursing  Students in South India Nurses in developing countries are frequently exposed to infectious tuberculosis (TB) patients, and have a high prevalence of TB infection. Devasahayam J et al found a high risk of TB infection among young nursing trainees, substantially higher than that seen in the general Indian population. Indian healthcare providers: PLoS One. 2011;6(10):e26199. Epub 2011 Oct 12 View more
«« « 49/ » »»

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
4.8/10 (تعداد آرا 12 نفر )
Copyright © 2011 AASM. All Rights Reserved.